Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics
about
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics StudiesLoss of Ypk1, the yeast homolog to the human serum- and glucocorticoid-induced protein kinase, accelerates phospholipase B1-mediated phosphatidylcholine deacylationLipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesNutritional lipidomics: molecular metabolism, analytics, and diagnosticsThe expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancerComparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate CellsProstate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New BiomarkersAn automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipidsA Combined PLS and Negative Binomial Regression Model for Inferring Association Networks from Next-generation Sequencing Count Data.Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus.Characterization of lipidic markers of chondrogenic differentiation using mass spectrometry imaging.Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.Lipidomic approach for stratification of acute myeloid leukemia patients.Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.Personalized medicine in screening for malignant disease: a review of methods and applications.Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.Prostate cancer: the need for biomarkers and new therapeutic targets.Dynamic and temporal assessment of human dried blood spot MS/MSALL shotgun lipidomics analysisLipidomics applications in health, disease and nutrition research.Novel approaches for the identification of biomarkers of aggressive prostate cancerDistinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.Lipid profiling of the filarial nematodes Onchocerca volvulus, Onchocerca ochengi and Litomosoides sigmodontis reveals the accumulation of nematode-specific ether phospholipids in the host.Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.Direct infusion mass spectrometry for metabolomic phenotyping of diseases.Lipid Profiling of In Vitro Cell Models of Adipogenic Differentiation: Relationships With Mouse Adipose Tissues.Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort.Functional genomics, genetics, and bioinformatics.Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreasMetabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma.Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer.Lipid emulsion enhances cardiac performance after ischemia-reperfusion in isolated hearts from summer-active arctic ground squirrels.GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells.LipidPedia: a comprehensive lipid knowledgebase.Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors.
P2860
Q26738585-D5E3C33B-F0E8-4D79-B02B-A5DA50F632F5Q27930785-D512394D-CDB0-4562-A29D-9B1FE0B18797Q28073169-0208D185-F427-49C2-BAE9-C23C83F37502Q28390150-BCC24579-DA99-4961-B721-41E600E78544Q28540259-FEA10203-66F9-47DC-9382-7015D05157BDQ28547040-C5A45C34-822E-4C21-8F74-2B8DE77441F3Q28550619-30FFEBD6-B1BD-428C-8FF0-FDBBF501647EQ28611371-F0A9FC3D-DCE4-4168-8A30-3BE83453C58DQ31161072-B3FF91A5-94D5-4A35-9B50-9E2B49EBA15FQ33872077-4A6F630C-2D48-4FE3-972D-8D2E75C63FA5Q34570007-3271A19F-22D2-488E-AFB4-6D3E15658E02Q35366944-A5170336-BC05-4A7E-AF82-44A13993E06DQ35762498-681E4B1A-CB8E-4675-B780-666C9811D97CQ35855382-A854B15E-B505-4A51-87B3-59DEDBA0A4CAQ36282427-FAAD3DC7-E644-4569-A0B5-5A8DCDE677A8Q36569962-D0D51CE8-224A-4519-AA4E-163A42461F64Q36641610-1DEB194F-F342-4638-95E6-77F92F958188Q37392792-1A9E5199-DF7D-44EB-B6F7-0794424F5197Q37476043-AB141F1F-1FFE-4EEC-ADF9-0BD7DDF43745Q37713619-96889992-553E-45B5-A3C9-703C0C09E6E8Q38111301-683D924C-F8CD-411B-8D1A-775C755564FEQ38117841-B8CB31D2-30C4-4CEA-9AC9-E0D6FA87C72CQ38654970-84DDAF22-8A88-49C2-B126-420E703C0F0BQ38661730-C640295C-55F2-43DA-B437-F26A3E7ACD55Q38838580-1B46C5AA-B49F-4DAB-9FD5-D4BD8AFBAE1EQ38964675-659355CB-0C2F-4AF6-A3E8-CD83EAD2035EQ39030360-8B164D7D-71BA-4E5F-ACF5-F0BEA26B9E15Q39972407-8E540A2E-D58F-4809-8E07-74EF5D856B19Q40224049-C9ACED9C-32D7-4C46-9421-7FCB8463A57BQ40317280-1E3EB21D-268B-422A-8D66-4423FAA7FA80Q41440976-9C51FF34-3EE3-44EF-A74D-95B6BF2CAE15Q42378320-4A796791-0717-41FA-B379-6DB686B97160Q46246621-8C3B1955-7274-422B-B980-D96C88E93A35Q47148343-DC91CBAC-ED61-417A-9197-C49CF6E0BA3FQ47203781-4507577E-16B0-4548-AECE-4C0F0513FFC6Q48339583-225CA974-57D0-488D-9EB4-01ADFC4B27C1Q52347460-9490D33B-8468-4601-9EF4-8F5F308FCA20Q52719848-84E4897D-516A-4A12-9635-6A40F7D86838Q52741776-C92AB0A5-AB8D-4FA7-A911-9721300D1ACCQ53186924-EE157123-E17A-47A3-974B-E8CA29266CDE
P2860
Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of plasma lipid ...... lipidomics and bioinformatics
@ast
Identification of plasma lipid ...... lipidomics and bioinformatics
@en
Identification of plasma lipid ...... lipidomics and bioinformatics
@nl
type
label
Identification of plasma lipid ...... lipidomics and bioinformatics
@ast
Identification of plasma lipid ...... lipidomics and bioinformatics
@en
Identification of plasma lipid ...... lipidomics and bioinformatics
@nl
prefLabel
Identification of plasma lipid ...... lipidomics and bioinformatics
@ast
Identification of plasma lipid ...... lipidomics and bioinformatics
@en
Identification of plasma lipid ...... lipidomics and bioinformatics
@nl
P2093
P2860
P1433
P1476
Identification of plasma lipid ...... lipidomics and bioinformatics
@en
P2093
Charles Pound
Jeffrey Henegar
Jinghe Mao
Mary R Roth
Steven A Bigler
Xinchun Zhou
P2860
P304
P356
10.1371/JOURNAL.PONE.0048889
P407
P577
2012-11-12T00:00:00Z